Endothelial-Vasoprotective Effects of High-Density Lipoprotein Are Impaired in Patients With Type 2 Diabetes Mellitus but Are Improved After Extended-Release Niacin Therapy

Sorrentino, Sajoscha A., Besler, Christian, Rohrer, Lucia, Meyer, Martin, Heinrich, Kathrin, Bahlmann, Ferdinand H., Mueller, Maja, Horváth, Tibor +10 more·2010·Circulation
DOI 10.1161/circulationaha.108.836346

Cited by (402)

Items 101–200 of 402

  1. High-Density Lipoprotein at the Interface of Type 2 Diabetes Mellitus And Cardiovascular Disorders
    Sophie Van Linthout, Frank Spillmann, Heinz‐Peter Schultheiss, Carsten Tschöpe · 2010 · Current Pharmaceutical Design
  2. The Therapeutic Role of Niacin in Dyslipidemia Management
    William E. Boden, Mandeep S. Sidhu, Peter Paul Toth · 2013 · Journal of Cardiovascular Pharmacology and Therapeutics
  3. Nutraceuticals in Cardiovascular Prevention: Lessons from Studies on Endothelial Function
    Cinzia Zuchi, Giuseppe Ambrosio, Thomas Felix Lüscher, Ulf Landmesser · 2010 · Cardiovascular Therapeutics
  4. Endothelial Dysfunction in Diabetes Is Aggravated by Glycated Lipoproteins; Novel Molecular Therapies
    Laura Toma, Camelia Sorina Stancu, Anca Volumnia Sima · 2020 · Biomedicines
  5. Myeloperoxidase, inflammation, and dysfunctional high-density lipoprotein
    Jonathan D. Smith · 2010 · Journal of clinical lipidology
  6. LDL-cholesterol versus non-HDL-to-HDL-cholesterol ratio and risk for coronary heart disease in type 2 diabetes
    Björn Eliasson, Soffia Guðbjörnsdóttir, Björn Zethelius, Katarina Eeg‐Olofsson, Jan Cederholm · 2013 · European Journal of Preventive Cardiology
  7. HDL-apoA-I Exchange: Rapid Detection and Association with Atherosclerosis
    Mark S. Borja, Lei Zhao, Bradley Hammerson, Chongren Tang, Richard Yang, Nancy Carson, Gayani Fernando, Xiaoqin Liu, Madhu S. Budamagunta, Jacques J. Genest et al. · 2013 · PLoS ONE
  8. Dysfunctional HDL: From Structure-Function-Relationships to Biomarkers
    Meliana Riwanto, Lucia Rohrer, Arnold von Eckardstein, Ulf Landmesser · 2014 · Handbook of experimental pharmacology
  9. Effects of triple antioxidant therapy on measures of cardiovascular autonomic neuropathy and on myocardial blood flow in type 1 diabetes: a randomised controlled trial
    Rodica Pop‐Busui, Martin J. Stevens, David M. Raffel, E. A. White, Mitali Mehta, Cynthia D. Plunkett, M. B. Brown, Eva L. Feldman · 2013 · Diabetologia
  10. Chemical Chaperones Mitigate Experimental Asthma by Attenuating Endoplasmic Reticulum Stress
    Lokesh Makhija, Veda Krishnan, Rakhshinda Rehman, Samarpana Chakraborty, Shuvadeep Maity, Ulaganathan Mabalirajan, Kausik Chakraborty, Balaram Ghosh, Anurag Agrawal · 2013 · American Journal of Respiratory Cell and Molecular Biology
  11. Antioxidant properties of drugs used in Type 2 diabetes management: could they contribute to, confound or conceal effects of antioxidant therapy?
    S. W. Choi, Cyrus Kin-chun Ho · 2017 · Redox Report
  12. Arterial stiffness evaluation by cardio-ankle vascular index in hypertension and diabetes mellitus subjects
    Hongyu Wang, Jinbo Liu, Hongwei Zhao, Xiaobao Fu, Guangyun Shang, Yingyan Zhou, Xiaolan Yu, Xujing Zhao, Guang Wang, Hongyan Shi · 2013 · Journal of the American Society of Hypertension
  13. Role of HDL in Those with Diabetes
    Carlos G. Santos‐Gallego, Robert S. Rosenson · 2014 · Current Cardiology Reports
  14. Elevated high-density lipoprotein in adolescents with type 1 diabetes is associated with endothelial dysfunction in the presence of systemic inflammation
    Chiesa, Scott T, Charakida, Marietta, McLoughlin, Eve, Nguyen, Helen C, Georgiopoulos, Georgios, Motran, Laura, Elia, Yesmino, Marcovecchio, M Loredana, Dunger, David B, Dalton, R Neil et al. · 2019 · European Heart Journal
  15. Pathophysiology of diabetic dyslipidemia:implications for atherogenesis and treatment
    Mary Sugden, Mark Holness · 2011 · Clinical Lipidology
  16. Niacin in Cardiovascular Disease: Recent Preclinical and Clinical Developments
    Janet E. Digby, Neil Ruparelia, Robin P. Choudhury · 2011 · Arteriosclerosis Thrombosis and Vascular Biology
  17. High-Density Lipoprotein Function in Cardiovascular Disease and Diabetes Mellitus
    Yi He, Vishal M Kothari, Karin Bornfeldt · 2018 · Arteriosclerosis Thrombosis and Vascular Biology
  18. High Density Lipoproteins and Diabetes
    Blake J. Cochran, Kwok Leung Ong, Bikash Manandhar, Kerry‐Anne Rye · 2021 · Cells
  19. Dysfunctional High-Density Lipoprotein Cholesterol and Coronary Artery Disease: A Narrative Review
    Cristina Madaudo, Giada Bono, Antonella Ortello, Giuseppe Astuti, Giulia Mingoia, Alfredo Ruggero Galassi, Vincenzo Sucato · 2024 · Journal of Personalized Medicine
  20. Effects of obesity on cholesterol metabolism and its implications for healthy ageing
    Mark T. Mc Auley · 2020 · Nutrition Research Reviews
  21. Walk-Run Training Improves the Anti-Inflammation Properties of High-Density Lipoprotein in Patients With Metabolic Syndrome
    Hui Sang, Shutong Yao, Liying Zhang, Xiuhong Li, Nana Yang, Jianxiang Zhao, Li Zhao, Yanhong Si, Ying Zhang, Xiaohong Lv et al. · 2014 · The Journal of Clinical Endocrinology & Metabolism
  22. Increasing HDL-cholesterol and prevention of atherosclerosis: A critical perspective
    Parhofer, Klaus G. · 2015 · Atherosclerosis Supplements
  23. Dysfunctional HDL in acute stroke
    Guadalupe Ortiz-Munoz, David Couret, Bertrand Lapergue, Éric Bruckert, Elena Meseguer, Pierre Amarenco, Olivier Meilhac · 2016 · Atherosclerosis
  24. Diabetic HDL Is Dysfunctional in Stimulating Endothelial Cell Migration and Proliferation Due to Down Regulation of SR-BI Expression
    Bing Pan, Yijing Ma, Hui Ren, Yubin He, Yongyu Wang, Xiaofeng Lv, Donghui Liu, Ji Liang, Baoqi Yu, Yuhui Wang et al. · 2012 · PLoS ONE
  25. Impairment of the Ability of HDL From Patients With Metabolic Syndrome but Without Diabetes Mellitus to Activate eNOS
    Damien Denimal, Serge Monier, Marie‐Claude Brindisi, Jean‐Michel Petit, Benjamin Bouillet, Amandine Nguyen, Laurent Demizieux, Isabelle Simoneau, Jean-Paul Paı̈s de Barros, Bruno L Vergès et al. · 2017 · Arteriosclerosis Thrombosis and Vascular Biology
  26. Effects of NAD+ precursor supplementation on glucose and lipid metabolism in humans: a meta-analysis
    Ou Zhong, Jinyuan Wang, Yongpeng Tan, Xiaocan Lei, Zhi‐Han Tang · 2022 · Nutrition & Metabolism
  27. Dysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and Lipidomics
    Juan José Salazar, Luis Carlos Olivar, Eduardo Ramos, Mervin Chávez-Castillo, Joselyn Rojas, Valmore Bermúdez · 2015 · Cholesterol
  28. Therapeutic Potential of HDL in Cardioprotection and Tissue Repair
    Sophie Van Linthout, Miguel A. Frias, Neha Singh, Bart De Geest · 2014 · Handbook of experimental pharmacology
  29. Dysfunctional High-Density Lipoproteins in Type 2 Diabetes Mellitus: Molecular Mechanisms and Therapeutic Implications
    Isabella Bonilha, Francesca Zimetti, Ilaria Zanotti, Bianca Papotti, Andrei Carvalho Sposito · 2021 · Journal of Clinical Medicine
  30. Structural and functional changes in HDL with low grade and chronic inflammation
    Francis O'Neill, Meliana Riwanto, Marietta Charakida, Sophie Colin, Jasmin Manz, Eve McLoughlin, Tauseef Ahmad Khan, Nigel Jonathan Klein, Christopher W. M. Kay, Kalpesh Patel et al. · 2015 · International Journal of Cardiology
  31. Myeloperoxidase levels predict accelerated progression of coronary atherosclerosis in diabetic patients: Insights from intravascular ultrasound
    Yu Kataoka, Mingyuan Shao, Kathy Wolski, Kiyoko Uno, Rishi Puri, Emin Murat Tuzcu, Stanley L. Hazen, Steven E. Nissen, Stephen James Nicholls · 2013 · Atherosclerosis
  32. Recombinant LCAT (Lecithin:Cholesterol Acyltransferase) Rescues Defective HDL (High-Density Lipoprotein)-Mediated Endothelial Protection in Acute Coronary Syndrome
    Alice Ossoli, Sara Simonelli, Marisa Varrenti, Nuccia Morici, Fabrizio Giovanni Oliva, Miriam Stucchi, Monica Gomaraschi, Arianna Strazzella, Lorenzo Arnaboldi, Michael J. Thomas et al. · 2019 · Arteriosclerosis Thrombosis and Vascular Biology
  33. Management of dyslipidemia in the elderly population
    Freij A. Gobal, Jawahar L. Mehta · 2010 · Therapeutic Advances in Cardiovascular Disease
  34. HDL Cholesterol as a Residual Risk Factor for Vascular Events and All-Cause Mortality in Patients With Type 2 Diabetes
    Shahnam Sharif, Yolanda van der Graaf, Hendrik M. Nathoe, Harold W. de Valk, Frank L.J. Visseren, Jan Westerink, on behalf of the SMART Study Group · 2016 · Diabetes Care
  35. Dysfunctional HDL as a Therapeutic Target for Atherosclerosis Prevention
    Alice Ossoli, Chiara Pavanello, Eleonora Giorgio, Laura Calabresi, Monica Gomaraschi · 2018 · Current Medicinal Chemistry
  36. Exercise training improves in vivo endothelial repair capacity of early endothelial progenitor cells in subjects with metabolic syndrome
    Kristina Sonnenschein, Tibor Horváth, Maja F. Mueller, Andrea Markowski, Tina Siegmund, Christian Jacob, Helmut Drexler, Ulf Landmesser · 2011 · European Journal of Cardiovascular Prevention & Rehabilitation
  37. Uraemic dyslipidaemia revisited: role of high-density lipoprotein
    Thimoteus Speer, Stephen Zewinger, Danilo Fliser · 2013 · Nephrology Dialysis Transplantation
  38. Niacin as antidyslipidemic drug
    Ulrich Julius · 2015 · Canadian Journal of Physiology and Pharmacology
  39. Serum Lipids, Apolipoproteins, and Mortality among Coronary Artery Disease Patients
    Ding Ding, Xinrui Li, Jian Qiu, Rui Li, Yuan Zhang, Dongfang Su, Zhongxia Li, Min Wang, Xiaofei Lv, Dongliang Wang et al. · 2014 · BioMed Research International
  40. Apolipoprotein A-1 mimetic peptide 4F promotes endothelial repairing and compromises reendothelialization impaired by oxidized HDL through SR-B1
    Dan He, Mingming Zhao, Congying Wu, Wenjing Zhang, Chenguang Niu, Baoqi Yu, Jingru Jin, Liang Ji, Belinda B. Willard, Anna Vachaparampil Mathew et al. · 2017 · Redox Biology
  41. High density lipoprotein cholesterol promotes the proliferation of bone-derived mesenchymal stem cells via binding scavenger receptor-B type I and activation of PI3K/Akt, MAPK/ERK1/2 pathways
    Jianfeng Xu, Juying Qian, Xinxing Xie, Lin Li, Jianying Ma, Zheyong Huang, Mingqiang Fu, Yunzeng Zou, Junbo Ge · 2012 · Molecular and Cellular Biochemistry
  42. The pleiotropic vasoprotective functions of high density lipoproteins (HDL)
    Guilaine K. Boyce, Emily B. Button, S.V. Sonja, Cheryl Lea Wellington · 2017 · Journal of Biomedical Research
  43. Impaired Endothelial Regeneration Through Human Parvovirus B19–Infected Circulating Angiogenic Cells in Patients With Cardiomyopathy
    Caroline Schmidt‐Lucke, Thomas Zobel, Sonja Schrepfer, Uwe Kühl, Dong Wang, Karin Klingel, Peter Moritz Becher, Henry Fechner, Tanja Pozzuto, Sophie Van Linthout et al. · 2015 · The Journal of Infectious Diseases
  44. Metabolism of HDL and its Regulation
    Dimitris Kardassis, Ioanna Mosialou, Maria Kanaki, Ioanna Tiniakou, Efstathia Thymiakou · 2014 · Current Medicinal Chemistry
  45. Structural Insights into High Density Lipoprotein: Old Models and New Facts
    Valentin Gogonea · 2016 · Frontiers in Pharmacology
  46. Altered HDL metabolism in metabolic disorders: insights into the therapeutic potential of HDL
    Nicholas Hui, Philip J. Barter, Kwok Leung Ong, Kerry‐Anne Rye · 2019 · Clinical Science
  47. Effect of niacin on endothelial function: A systematic review and meta-analysis of randomized controlled trials
    Amirhossein Sahebkar · 2014 · Vascular Medicine
  48. The Therapeutic Potential of Anti-Inflammatory Exerkines in the Treatment of Atherosclerosis
    Megan Yu, Sheng‐Feng Tsai, Yu‐Min Kuo · 2017 · International Journal of Molecular Sciences
  49. High-density lipoprotein remodelled in hypercholesterolaemic blood induce epigenetically driven down-regulation of endothelial HIF-1α expression in a preclinical animal model
    Soumaya Ben‐Aicha, Rafael Escate, Laura Casaní, Teresa Padró, Esther Peña, Gemma Arderiu, Guiomar Mendieta, Lina Badimón, Gemma Vilahur · 2019 · Cardiovascular Research
  50. BMI modifies the association between serum HDL cholesterol and stroke in a hypertensive population without atrial fibrillation
    Yu Yu, Lidong Hu, Xiao Bo Huang, Wei Zhou, Huihui Bao, Xiaoshu Cheng · 2020 · Journal of Endocrinological Investigation
  51. Predictive value of the serum uric acid to high-density lipoprotein cholesterol ratio for culprit plaques in patients with acute coronary syndrome
    Fuxue Deng, Fang Jia, Yang Sun, Lisha Zhang, Jie Han, Danni Li, Qiang Yang, Rongrong Hou, Wei Jiang · 2024 · BMC Cardiovascular Disorders
  52. Statins, HMG-CoA Reductase Inhibitors, Improve Neovascularization by Increasing the Expression Density of CXCR4 in Endothelial Progenitor Cells
    Kuang‐Hsing Chiang, Wanli Cheng, Chun‐Ming Shih, Yi‐Wen Lin, Nai-Wen Tsao, Yung‐Ta Kao, Chih‐Ting Lin, Shinn‐Chih Wu, Chun‐Yao Huang, Feng‐Yen Lin · 2015 · PLoS ONE
  53. Oxidized High-Density Lipoprotein Impairs Endothelial Progenitor Cells' Function by Activation of CD36-MAPK-TSP-1 Pathways
    Jianxiang Wu, Zhiqing He, Xiang Gao, Feng Wu, Ru Ding, Yusheng Ren, Qijun Jiang, Min Fan, Chun Liang, Zonggui Wu · 2014 · Antioxidants and Redox Signaling
  54. Lipids, lipid-lowering therapy and diabetes complications
    Paul Elie Valensi, Sylvie Picard · 2010 · Diabetes & Metabolism
  55. Effect of niacin on lipids and glucose in patients with type 2 diabetes: A meta-analysis of randomized, controlled clinical trials
    Yi Ding, Yuwen Li, Aidong Wen · 2014 · Clinical Nutrition
  56. The interaction between uric acid and high-density lipoprotein cholesterol on the prognosis of patients with acute myocardial infarction
    Yu Yang, Jian Zhang, Lin Jia, Jian-Nan Su, Mengqing Ma, Xianhe Lin · 2023 · Frontiers in Cardiovascular Medicine
  57. High-Density Lipoprotein Alterations in Type 2 Diabetes and Obesity
    Damien Denimal, Serge Monier, Benjamin Bouillet, Bruno L Vergès, Laurence Duvillard · 2023 · Metabolites
  58. High Density Lipoprotein: A Therapeutic Target in Type 2 Diabetes
    Philip J. Barter · 2013 · Endocrinology and Metabolism
  59. High-Density Lipoprotein Subspecies in Health and Human Disease: Focus on Type 2 Diabetes
    William Sean Davidson, AMY SANGHAVI SHAH · 2019 · Methodist DeBakey Cardiovascular Journal
  60. Dysfunctional High-density Lipoprotein: The Role of Myeloperoxidase and Paraoxonase-1
    Tiziana Bacchetti, Gianna Ferretti, Federico Carbone, Stefano Ministrini, Fabrizio Montecucco, Tannaz Jamialahmadi, Amirhossein Sahebkar · 2020 · Current Medicinal Chemistry
  61. HDL cholesterol efflux capacity is inversely associated with subclinical cardiovascular risk markers in young adults: The cardiovascular risk in Young Finns study
    Monika Hunjadi, Claudia Lamina, Patrick Kahler, Tamara Bernscherer, Jorma S.A. Viikari, Terho J. Lehtimäki, Mika A. P. Kähönen, Mikko Hurme, Markus Juonala, Leena M Taittonen et al. · 2020 · Scientific Reports
  62. Cholesterol Efflux Capacity
    Amit V. Khera, Daniel James Rader · 2013 · Arteriosclerosis Thrombosis and Vascular Biology
  63. Association of serum uric acid to high-density lipoprotein cholesterol ratio with all-cause and cardiovascular mortality in patients with diabetes or prediabetes: a prospective cohort study
    Xiaoli Lai, Tao Chen · 2024 · Frontiers in Endocrinology
  64. HDL-C: clinical equipoise and vascular endothelial function
    Steven Campbell, Jacques J. Genest · 2013 · Expert Review of Cardiovascular Therapy
  65. Impaired HDL function in obese adolescents: Impact of lifestyle intervention and bariatric surgery
    Yae Matsuo, Andreas Oberbach, Holger Till, Thomas H. Inge, Martin Wabitsch, Anja Moß, Nico Jehmlich, Uwe Völker, Ulrike Müller, Wolfgang Siegfried et al. · 2013 · Obesity
  66. Increasing high-density lipoprotein cholesterol by cholesteryl ester transfer protein-inhibition: a rocky road and lessons learned? The early demise of the dal-HEART programme
    Ulf Landmesser, Arnold von Eckardstein, John J.P. Kastelein, John Eric Deanfield, Thomas Felix Lüscher · 2012 · European Heart Journal
  67. High-density lipoprotein from patients with coronary heart disease loses anti-thrombotic effects on endothelial cells: impact on arterial thrombus formation
    Erik Walter Holy, Christian Besler, Martin F. Reiner, Giovanni Guido Camici, Jasmin Manz, Jürg Hans Beer, Thomas Felix Lüscher, Ulf Landmesser, Felix Christoph Tanner · 2014 · Thrombosis and Haemostasis
  68. High-density lipoprotein cholesterol as a predictor of poor survival in patients with nasopharyngeal carcinoma
    Yanyan Liu, Shao-jun Lin, Yuanyuan Chen, Li-Na Liu, Liu-Bin Bao, Lin‐Quan Tang, Jing-Song Ou, Zhi-Gang Liu, Xiao-Zhong Chen, Yan Xu et al. · 2016 · Oncotarget
  69. The Role of Selected lncRNAs in Lipid Metabolism and Cardiovascular Disease Risk
    Anna Gluba-Brzózka, Beata Franczyk, Aleksandra Rysz-Górzyńska, Robert Olszewski, Jacek Rysz · 2024 · International Journal of Molecular Sciences
  70. 2013 ESC/EASD guidelines on the management of diabetes and cardiovascular disease: Established knowledge and evidence gaps
    Francesco Paneni · 2013 · Diabetes and Vascular Disease Research
  71. Examining the paradox of high high-density lipoprotein and elevated cardiovascular risk
    Kavisha Singh, Anand K. Rohatgi · 2018 · Journal of Thoracic Disease
  72. Association of extremely high levels of high-density lipoprotein cholesterol with endothelial dysfunction in men
    Yuji Takaeko, Shogo Matsui, Masato Kajikawa, Tatsuya Maruhashi, Shinji Kishimoto, Haruki Hashimoto, Yasuki Kihara, Eisuke Hida, Kazuaki Chayama, Chikara Goto et al. · 2019 · Journal of clinical lipidology
  73. Understanding Myeloperoxidase-Induced Damage to HDL Structure and Function in the Vessel Wall: Implications for HDL-Based Therapies
    Gunther Marsche, Julia T. Stadler, Julia Kargl, Michael Holzer · 2022 · Antioxidants
  74. ApoA-I and Diabetes
    Thomas W King, Blake J. Cochran, Kerry‐Anne Rye · 2023 · Arteriosclerosis Thrombosis and Vascular Biology
  75. HDL does not influence the polarization of human monocytes toward an alternative phenotype
    Sophie Colin, Mélanie Fanchon, Loïc Belloy, Andrea E. Bochem, Corinne Copin, Bruno Derudas, Erik S.G. Stroes, G. Kees Hovingh, Jan Albert Kuivenhoven, Geesje M. Dallinga‐Thie et al. · 2014 · International Journal of Cardiology
  76. Glycoxidized HDL, HDL Enriched With Oxidized Phospholipids and HDL From Diabetic Patients Inhibit Platelet Function
    Quang Huy Lê, Meddy El Alaoui, Evelyne Véricel, Bérénice Segrestin, Laurent Soulère, Michel Guichardant, Michel Lagarde, Philippe Moulin, Catherine Calzada · 2015 · The Journal of Clinical Endocrinology & Metabolism
  77. Pathophysiology and Prevention of Heart Disease in Diabetes Mellitus
    Ahmet Afşin Oktay, Halis Kaan Aktürk, Kerim Esenboğa, Fahad Javed, Nichole M. Polin, Eiman Jahangir · 2017 · Current Problems in Cardiology
  78. Changing Perspectives on HDL: From Simple Quantity Measurements to Functional Quality Assessment
    Himani Thakkar, Vinnyfred Vincent, Atanu Sen, Archna Singh, Ambuj Roy · 2021 · Journal of Lipids
  79. High density lipoprotein from patients with valvular heart disease uncouples endothelial nitric oxide synthase
    Feng-Jun Chang, Haiyun Yuan, Xiaoxia Hu, Zhi‐Jun Ou, Li Fu, Ze‐Bang Lin, Zhiping Wang, Shenming Wang, Li Zhou, Ying-Qi Xu et al. · 2014 · Journal of Molecular and Cellular Cardiology
  80. Effects of Established Hypolipidemic Drugs on HDL Concentration, Subclass Distribution, and Function
    Monica Gomaraschi, Maria Pia Adorni, Maciej Banach, Franco Bernini, Guido Franceschini, Laura Calabresi · 2014 · Handbook of experimental pharmacology
  81. Controversies in the cardiovascular management of type 2 diabetes
    Lionel Henry Opie, Derek M. Yellon, Bernard John Gersh · 2010 · Heart
  82. Proteome profiles of HDL particles of patients with chronic heart failure are associated with immune response and also include bacteria proteins
    Andreas Oberbach, Volker Adams, Nadine S. Schlichting, Marco Heinrich, Yvonne Kullnick, Stefanie Lehmann, Sven Lehmann, Stefan Feder, João Carlos Correia, Friedrich‐Wilhelm Mohr et al. · 2015 · Clinica Chimica Acta
  83. Niacin improves lipid profile but not endothelial function in patients with coronary artery disease on high dose statin therapy
    Andrew C. Philpott, Jaroslav Hubacek, Yizhe Sun, Darlene Hillard, Todd J. Anderson · 2012 · Atherosclerosis
  84. Reversing Heart Failure–Associated Pathophysiology with Exercise
    Volker Adams, Josef Niebauer · 2014 · Heart Failure Clinics
  85. Cardioprotective Properties of HDL: Structural and Functional Considerations
    Eleni T. Pappa, Moses Elisaf, Christina E. Kostara, Eleni Th Bairaktari, Vasilis Tsimihodimos · 2019 · Current Medicinal Chemistry
  86. The impact of aerobic and isometric exercise on different measures of dysfunctional high-density lipoprotein in patients with hypertension
    Nikolaos Pagonas, Stergios Vlatsas, Frederic Bauer, Felix Sebastian Seibert, Benjamin Michel Sasko, Ivo R Buschmann, Oliver Ritter, Theodoros Kelesidis, Timm Henning Westhoff · 2019 · European Journal of Preventive Cardiology
  87. Impact of Lifestyle Intervention on HDL-Induced eNOS Activation and Cholesterol Efflux Capacity in Obese Adolescent
    Jenny Wesnigk, Luc Bruyndonckx, Vicky Y. Hoymans, Ann De Guchtenaere, Tina Fischer, Gerhard C Schuler, Christiaan J. Vrints, Volker Adams · 2016 · Cardiology Research and Practice
  88. Predictive and protective role of high-density lipoprotein cholesterol in acute myocardial infarction
    Jin Sup Park, Kwang Soo Cha, Hye Won Lee, Jun‐Hyok Oh, Jung Hyun Choi, Han Cheol Lee, Taek Jong Hong, Myung Ho Jeong, Shung Chull Chae, Young‐Jo Kim · 2013 · Cardiology Journal
  89. Apolipoprotein A1 Inhibits the TGF-β1-Induced Endothelial-to-Mesenchymal Transition of Human Coronary Artery Endothelial Cells
    Juling Feng, Jingjing Zhang, Ampadu O. Jackson, Xiao Zhu, Hainan Chen, Wen Chen, Qingjun Gui, Kai Yin · 2017 · Cardiology
  90. Niacin action in the atherogenic mixed dyslipidemia of metabolic syndrome: Insights from metabolic biomarker profiling and network analysis
    Martin Adiels, M. John Chapman, Paul Robillard, Michel Krempf, Martine Laville, Jan Borén · 2018 · Journal of clinical lipidology
  91. High-density lipoprotein cholesterol and causes of death in chronic kidney disease
    Sankar Dass Navaneethan, Jesse D. Schold, Carl Peter Walther, Susana Arrigain, Stacey E. Jolly, Salim S. Virani, Wolfgang C. Winkelmayer­, Joseph V. Nally · 2018 · Journal of clinical lipidology
  92. High-Density Lipoproteins
    Arash Haghikia, Ulf Landmesser · 2018 · Cardiology Clinics
  93. Changes in High-Density Lipoproteins Related to Outcomes in Patients with Acute Stroke
    Lourdes M. Varela, Elena Meseguer, Bertrand Lapergue, David Couret, Pierre Amarenco, Olivier Meilhac · 2020 · Journal of Clinical Medicine
  94. High density lipoprotein and cardiovascular diseases
    Theodosios D. Filippatos · 2013 · World Journal of Cardiology
  95. Anti-TNFα therapy transiently improves high density lipoprotein cholesterol levels and microvascular endothelial function in patients with rheumatoid arthritis: a Pilot Study
    Aamer Sandoo, Jet Veldhuijzen Zanten, Tracey E. Toms, Douglas Carroll, George D. Kitas · 2012 · BMC Musculoskeletal Disorders
  96. Hepatocyte-specific ABCA1 transfer increases HDL cholesterol but impairs HDL function and accelerates atherosclerosis
    Yingmei Feng, Joke Lievens, Frank Jacobs, Menno Hoekstra, Eline Van Craeyveld, Stephanie C. Gordts, Jan Snoeys, Bart De Geest · 2010 · Cardiovascular Research
  97. Inflammation Alters Relationship Between High‐Density Lipoprotein Cholesterol and Cardiovascular Risk in Patients With Chronic Kidney Disease: Results From KNOW‐CKD
    Jae Young Kim, Jung Tak Park, Hyung Woo Kim, Tae Ik Chang, Ea Wha Kang, Curie Ahn, Kook‐Hwan Oh, Joongyub Lee, Wookyung Chung, Yong‐Soo Kim et al. · 2021 · Journal of the American Heart Association
  98. The Biphasic Effects of Oxidized-Low Density Lipoprotein on the Vasculogenic Function of Endothelial Progenitor Cells
    Feng‐Yen Lin, Nai-Wen Tsao, Chun‐Ming Shih, Yi‐Wen Lin, Jong‐Shiuan Yeh, Jaw‐Wen Chen, Hironori Nakagami, Ryuichi Morishita, Tatsuya Sawamura, Chun‐Yao Huang · 2015 · PLoS ONE
  99. Effectiveness of niacin supplementation for patients with type 2 diabetes
    Dan Xiang, Qian Zhang, Yangtian Wang · 2020 · Medicine
  100. Relationship between cardio-ankle vascular index and plasma lipids in hypertension subjects
    H Wang, J Liu, Hongqing Zhao, Xiaoxiao Zhao, L Li, Hongbin Shi, Siyan Zhan, J Liu · 2014 · Journal of Human Hypertension